Literature DB >> 6840231

Serum lysosomal enzyme activities in silicosis and asbestosis.

H Koskinen, J Järvisalo, M S Huuskonen, T Koivula, P Mutanen, E Pitkänen.   

Abstract

The serum activities of two lysosomal enzymes, beta-N-acetylglucosaminidase (EC 3.2.1.30) and beta-glucuronidase (EC 3.2.1.31) were analyzed for 28 silicosis and 34 asbestosis patients. The enzyme activities of the patients were compared with those of age-, sex- and exposure-matched controls with no radiological signs of pneumoconiosis, and with an additional reference group of blood donors. The serum activity of beta-N-acetylglucosaminidase was higher in the silicosis patients (32.5 +/- 11.7 U/l) than in the asbestosis patients (21.7 +/- 7.9 U/l, p less than 0.001), in the silica exposed controls (27.1 +/- 6.7 U/l, p less than 0.05) or in the blood donors (24.8 +/- 6.3 U/l, p less than 0.05). No significant differences were found in the serum activity of beta-glucuronidase in the studied groups. Although the mechanisms causing different levels of serum beta-N-acetylglucosaminidase activity in silicosis and asbestosis patients remain unresolved, they may be related to the different mechanisms of action of the two dusts on lung (10).

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6840231

Source DB:  PubMed          Journal:  Eur J Respir Dis        ISSN: 0106-4339


  3 in total

1.  Serum angiotensin-converting enzyme and lysosomal enzymes in asbestosis.

Authors:  M S Huuskonen; J Jävisalo; H Koskinen; H Kivistö
Journal:  Lung       Date:  1986       Impact factor: 2.584

2.  Red blood cell anti-oxidant parameters in silicosis.

Authors:  P J Borm; A Bast; E F Wouters; J J Slangen; G M Swaen; T de Boorder
Journal:  Int Arch Occup Environ Health       Date:  1986       Impact factor: 3.015

3.  Role of nitric oxide in muscle regeneration following eccentric muscle contractions in rat skeletal muscle.

Authors:  Tomonobu Sakurai; Osamu Kashimura; Yutaka Kano; Hideki Ohno; Li Li Ji; Tetsuya Izawa; Thomas M Best
Journal:  J Physiol Sci       Date:  2013-04-21       Impact factor: 2.781

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.